TrialOncotarget2017

Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.

Hyo Song Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.